These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6217579)

  • 1. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia.
    Higgins DL; Lewis SD; Penner JA; Shafer JA
    Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new dysfibrinogenemia: fibrinogen Oslo IV.
    Stormorken H; Brosstad F; Seim H
    Thromb Haemost; 1983 Apr; 49(2):120-2. PubMed ID: 6868008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain].
    Rupp C; Sievi R; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
    Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L; Koopman J; de Munk G; Haverkate F; Nováková I; Verheijen JH; Briët E; Brommer EJ
    Thromb Haemost; 1988 Aug; 60(1):113-20. PubMed ID: 3142089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF; Schreiler WE; Bell WR
    Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
    Southan C; Kehl M; Henschen A; Lane DA
    Br J Haematol; 1983 May; 54(1):143-51. PubMed ID: 6849832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
    Seydewitz HH; Gram J; Bruhn HD; Witt I
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
    Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
    Vila V; Regañón E; Aznar J; Navarro G; Salas M
    Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
    Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
    Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M; Leupin L; Biasiutti FD; Lämmle B
    Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen and dysfibrinogenemia.
    Morse EE
    Ann Clin Lab Sci; 1980; 10(4):351-5. PubMed ID: 7447388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR; Prchal JT; Mosesson MW
    Blood; 1988 Mar; 71(3):613-8. PubMed ID: 3345340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.